Clinical trial
Actos Now for Prevention of Diabetes (ACT NOW)
NCT00220961 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00220961 |
|---|---|
| Title | Actos Now for Prevention of Diabetes (ACT NOW) |
| Official title | Actos Now for Prevention of Diabetes (ACT NOW) |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | University of Texas Takeda Pharmaceuticals North America, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Impaired Glucose Tolerance, Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Pioglitazone, Placebo |
| Enrollment | 602 |
| Start date | Jan 1, 2004 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: